My Path from Hiroshima to Houston.

R. Komaki

DOI: https://doi.org/10.1016/j.prro.2017.10.006

IF: 3.439

2017-10-13

Practical Radiation Oncology

Abstract:

What problem does this paper attempt to address?

Towards better uncertainty handling based on zSlices and general type-2 fuzzy logic systems

Christian Wagner

Abstract:
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Christoph A. Diebolder,Frank J. Beurskens,Rob N. de Jong,Roman I. Koning,Kristin Strumane,Margaret A. Lindorfer,Marleen Voorhorst,Deniz Ugurlar,Sara Rosati,Albert J. R. Heck,Jan G. J. van de Winkel,Ian A. Wilson,Abraham J. Koster,Ronald P. Taylor,Erica Ollmann Saphire,Dennis R. Burton,Janine Schuurman,Piet Gros,Paul W. H. I. Parren

DOI: https://doi.org/10.1126/science.1248943

IF: 56.9

2014-03-14

Science

Abstract:Hexing Complement Complement activation is an immediate and potent immune defense mechanism, but how immunoglobulin G (IgG) antibodies activate complement at the molecular level is poorly understood. Using high-resolution crystallography, Diebolder et al. (p. 1260 ) show that human IgGs form hexameric structures by interacting with neighboring IgG molecules, and the complex then activates complement. Thus, IgG molecules and the complement system can coexist in the blood because complement activation will only be triggered after IgG senses a surface antigen and starts to aggregate.

multidisciplinary sciences
Postoperative surgical site infections in cardiac surgery —an overview of preventive measures

B. Gårdlund

DOI: https://doi.org/10.1111/j.1600-0463.2007.00845.x

2007-09-01

Abstract:Postoperative surgical site infections are a major cause of postoperative morbidity and mortality in cardiac surgery. A surgical site infection occurs when the contaminating pathogens overcome the host defense systems and an infectious process begins. Bacteria may enter the operating site either by direct contamination from the patient's skin or internal organs, through the hands and instruments of the surgical staff or by bacteria‐carrying particles that float around in the operating theatre and may land in the wound. The ability to withstand the contaminating bacteria depends on both local and systemic host defense. Successful preventive strategies are multiple and must include: 1) Minimizing the bacterial contamination of the surgical site (skin preparation, operating room ventilation, scrubbing, double gloving, etc.), 2) Minimizing the consequences of virulent contaminating bacteria by antibiotic prophylaxis (adequate dose, sort, timing, duration), 3) Minimizing injury to local host defense (atraumatic surgery, no excessive electrocautery, meticulous hemostasis, etc.), and 4) Optimizing general host defense (nutrition, tobacco smoking, weight loss, etc.). Compliance with these preventive procedures must be enforced through regular reviews of performance. Non‐compliance with hygiene routines is often due to ignorance and poor planning. Education of personnel in these issues is a continuous process.
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

M. E. van der Tol,J. Verhoef,R. Peters,W. V. van Dijk,H. Verbrugh

1979-07-01

Immunology

Abstract:The role of cell-wall peptidoglycan, teichoic acid and protein A in the processes of Staphylococcus aureus complement activation and opsonization was investigated. CH50 consumption studies reveal that, although all cell-surface fractions were capable of activating the classical C pathway, only peptidoglycan consumed C via the alternative pathway. Using a quantitative immunofluorescence assay, peptidoglycan was shown to bind C3 molecules via the classical as well as via the alternative C pathway and in the absence of IgG and IgA class antibodies. C activation via the classical and the alternative pathway could be distinguished by kinetic analysis. By comparing the rates of staphylococcal C consumption, C3 fixation and opsonization it was found that the CH50 consumption assay is a relatively insensitive method and may yield results that do not necessarily reflect the process of bacterial opsonization.

Biology,Medicine
Teaching Test-Taking Strategies to Improve the Academic Achievement of Students with Mild Mental Disabilities.

Allison G. Kretlow,Ya-yu Lo,Richard B. White,L. Jordan

2008-09-01

Abstract:This study examined the effects of teaching a test-taking strategy to 4 fourthand fifth-grade students with mild mental disabilities on reading and math achievement. The intervention consisted of a direct and explicit instructional method using a mnemonic strategy. The participants’ acquisition and application of the test-taking strategy on reading and math probes were evaluated using a multiple probe across participants design. All participants demonstrated the ability to apply the strategy on probes during the intervention, 2-week maintenance, and generalization conditions. Significant gains in achievement were observed for all participants. Implications of teaching test-taking strategies to students with mild to moderate mental disabilities were discussed. As achievement accountability measures continue to increase in the public education system, so do the expectations for students with disabilities. Current legislation enforces the need for students with disabilities to have access to the general education curriculum, and in turn for states to assess those students through standardized achievement measures. The No Child Left Behind Act (NCLB) of 2001 requires that all students in grades three through eight take state-wide achievement tests in reading and math (Goertz & Duffy, 2003). The NCLB Act in combination with the amendments to the Individuals with Disabilities Education Improvement Act (IDEIA, 2004), which states that all students must be included in state and district assessments, present challenges of test-taking to students with disabilities (Washburn-Moses, 2003). The performance of students with disabilities on standardized achievement tests is at least, in part, responsible for states attaining what the federal government outlined in the NCLB Act as Adequately Yearly Progress (AYP). To meet AYP, schools must attain goals related to achievement for certain targeted groups of students, including students with disabilities. As a result, performance on standardized achievement tests has high stakes for students with disabilities. Additionally, school districts may use test scores of students with disabilities to decide placement, grade level promotion, or to determine whether or not a student graduates (Heubert & Hauser, 1999). By the nature of their disabilities, many students in special education programs have difficulty demonstrating knowledge through standardized achievement tests. Specifically, students with disabilities have difficulty with cognitive and metacognitive task demands. They often need help to approach a learning activity (such as test taking), and require systematic methods of training to acquire thinking skills (Henley, Ramsey, & Algozzine, 2005). Students with disabilities also often have difficulty organizing information and responding to complex questions. For example, a student with a learning disability may have content knowledge (e.g., in math or science), but have difficulty demonstrating the knowledge in a standardized format. In other words, students’ lack of test taking skills may appear as academic deficiencies (Scruggs & Marsing,
The role of gamma globulin, complement component 1q, factor B, properdin, body temperature, C-reactive protein and serum amyloid alpha to the activity and the function of the human complement system and its pathways

Janne Atosuo,Outi Karhuvaara,Eetu Suominen,Julia Virtanen,Liisa Vilén,Jari Nuutila

DOI: https://doi.org/10.1016/j.jim.2024.113709

IF: 2.287

2024-06-11

Journal of Immunological Methods

Abstract:The complement system plays a crucial role in orchestrating the activation and regulation of inflammation within the human immune system. Three distinct activation pathways—classical, lectin, and alternative—converge to form the common lytic pathway, culminating in the formation of the membrane-attacking complex that disrupts the structure of pathogens. Dysregulated complement system activity can lead to tissue damage, autoimmune diseases, or immune deficiencies. In this study, the antimicrobial activity of human serum was investigated by using a bioluminescent microbe probe, Escherichia coli (pEGFPluxABCDEamp). This probe has previously been used to determine the antimicrobial activity of complement system and the polymorphonuclear neutrophils. In this study, blocking antibodies against key serum activators and components, including IgG, complement component 1q, factor B, and properdin, were utilized. The influence of body temperature and acute phase proteins, such as C reactive protein (CRP) and serum amyloid alpha (SAA), on the complement system was also examined. The study reveals the critical factors influencing complement system activity and pathway function. Alongside crucial factors like C1q and IgG, alternative pathway components factor B and properdin played pivotal roles. Results indicated that the alternative pathway accounted for approximately one third of the overall serum antimicrobial activity, and blocking this pathway disrupted the entire complement system. Contrary to expectations, elevated body temperature during inflammation did not enhance the antimicrobial activity of human serum. CRP demonstrated complement activation properties, but at higher physiological concentrations, it exhibited antagonistic tendencies, dampening the response. On the other hand, SAA enhanced the serum's activity. Overall, this study sheds a light on the critical factors affecting both complement system activity and pathway functionality, emphasizing the importance of a balanced immune response.

immunology,biochemical research methods
Factors affecting IgG4-mediated complement activation

Nienke Oskam,Timon Damelang,Marij Streutker,Pleuni Ooijevaar-de Heer,Jan Nouta,Carolien Koeleman,Julie Van Coillie,Manfred Wuhrer,Gestur Vidarsson,Theo Rispens

DOI: https://doi.org/10.3389/fimmu.2023.1087532

IF: 7.3

2023-01-26

Frontiers in Immunology

Abstract:Of the four human immunoglobulin G (IgG) subclasses, IgG4 is considered the least inflammatory, in part because it poorly activates the complement system. Regardless, in IgG4 related disease (IgG4-RD) and in autoimmune disorders with high levels of IgG4 autoantibodies, the presence of these antibodies has been linked to consumption and deposition of complement components. This apparent paradox suggests that conditions may exist, potentially reminiscent of in vivo deposits, that allow for complement activation by IgG4. Furthermore, it is currently unclear how variable glycosylation and Fab arm exchange may influence the ability of IgG4 to activate complement. Here, we used well-defined, glyco-engineered monoclonal preparations of IgG4 and determined their ability to activate complement in a controlled system. We show that IgG4 can activate complement only at high antigen and antibody concentrations, via the classical pathway. Moreover, elevated or reduced Fc galactosylation enhanced or diminished complement activation, respectively, with no apparent contribution from the lectin pathway. Fab glycans slightly reduced complement activation. Lastly, we show that bispecific, monovalent IgG4 resulting from Fab arm exchange is a less potent activator of complement than monospecific IgG4. Taken together, these results imply that involvement of IgG4-mediated complement activation in pathology is possible but unlikely.

immunology
Mode of complement activation by acidic heteroglycans from the leaves of Artemisia princeps PAMP

H Yamada,T Nagai,J C Cyong,Y Otsuka

DOI: https://doi.org/10.1248/cpb.39.2077

Abstract:The mode of action of the anti-complementary acidic heteroglycans, AAF-IIb-2 and IIb-3 which consisted of rhamnogalacturonan core and arabinogalactan moieties, purified from the leaves of Artemisia princeps PAMP (Japanese name = Gaiyo) were investigated. The anti-complementary activities of AAF-IIb-2 and IIb-3 were reduced partially in the absence of Ca2+ ions. A marked consumption of C4 was observed to have occurred when serum was incubated with both polysaccharides in the presence of Ca2+ ions. AAF-IIb-2 showed more potent C4 consumption than IIb-3. After the incubation of the serum with AAF-IIb-2 in the absence of Ca2+ ions, a cleavage of C3 in the serum was detected by immunoelectrophoresis. AAF-IIb-2 showed more significant consumption of the complement than IIb-3 when rabbit erythrocytes were used in the assay system in the absence of Ca2+ ions. These results indicate that AAF-IIb-2 activates the complement via both the alternative and classical pathways, whereas IIb-3 mainly activates the complement via the classical pathway. The absorption of serum with Protein A-Sepharose results in a decrease of the activity of AAF-IIb-2 and IIb-3. However, the decrease of the activity was restored by the replacement of the immunoglobulin G (IgG) fraction after its recovery from the Protein A-Sepharose. These results suggest that IgG dependent mechanisms are both involved in the anti-complementary activity of AAF-IIb-2 and IIb-3.
Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

Nikolaus Frischauf,Jürgen Strasser,Ellen G.F. Borg,Aran F. Labrijn,Frank J. Beurskens,Johannes Preiner

DOI: https://doi.org/10.1101/2024.03.26.586731

2024-03-29

Abstract:Complement activation through antibody-antigen complexes is crucial in various pathophysiological processes such as infections, inflammation, and autoimmunity, but is also utilized in immunotherapies to eliminate infectious agents, regulatory immune cells, or cancer cells. Although the tertiary structures of the four IgG antibody subclasses are largely identical, complement recruitment and further activation depend strongly on subclass, which is commonly explained by the respective affinity for C1, the first component of the classical complement pathway. Contradicting this established view, we here demonstrate that complement activation by different IgG subclasses is determined by their varying ability to form IgG oligomers on antigenic surfaces large enough to multivalently bind and activate C1. We directly visualize the resulting IgG oligomer structures and characterize their distribution by means of high-speed atomic force microscopy (HS-AFM), quantify their complement recruitment efficiency from quartz crystal microbalance (QCM) experiments, and characterize their ability to activate complement on tumor cell lines as well as in vesicle-based complement lysis assays. We present a mechanistic model of the multivalent interactions that govern C1 binding to IgG oligomers and use this model to extract affinities and kinetic rate constants from real-time interaction QCM data. Together, our detailed characterization yields a comprehensive view on the parameters that govern complement activation by the different IgG subclasses, which may inform the design of future antibody therapies.

Immunology
The Fc fragment of soluble IgMs binds C1q to activate the classical complement pathway, while inhibiting complement-dependent cytotoxicity

Andre J. Pinto,Anne Chouquet,Isabelle Bally,Nicole M. Thielens,Chantal Dumestre-Perard,Renate Kunert,Christine Gaboriaud,Wai Li W Ling,Jean-Baptiste REISER

DOI: https://doi.org/10.1101/2024.07.10.602503

2024-07-11

Abstract:Soluble type-M immunoglobulins (IgMs), among the most potent activators of the classical pathway, are key mediators of complement-dependent cytotoxicity, which render them promising candidates for developing alternative drugs in treating autoimmune or inflammatory diseases. In this study, we investigated the biochemical and in vitro functional properties of recombinant fragments from IgMs corresponding to the Fc-core in their two pentameric or hexameric forms. Biophysical experiments confirmed the crucial role of the IgM Joining chain (J) in favoring homogenous pentamers, while its absence led to heterogeneous population with a mixture of oligomeric forms. By combining size-exclusion chromatography with mass photometry, isolation of enriched samples with IgM hexamers or IgM pentamers without the J chain was possible. Biolayer interferometry demonstrated that both IgM-Fc forms bind C1q and ELISA showed that they induce the in vitro C4b deposition when in solid phase. Additionally, our data confirmed the higher efficacy of IgM hexamers compared to pentamers in activating the first component of the classical pathway. Finally, hemolytic assays demonstrate the ability of IgM-Fc constructs to inhibit Ig-induced complement-dependent cytotoxicity. These findings provide important information for the ultimate development of IgM-based molecules that target specifically complement activation.

Biochemistry
C3 Shunt Activation in Human Serum Chelated with EGTA

Douglas P. Fine,Samuel R. Marney,Daniel G. Colley,John S. Sergent,Roger M. Des Prez

DOI: https://doi.org/10.4049/jimmunol.109.4.807

1972-10-01

The Journal of Immunology

Abstract:Abstract Complement (C) fixation via the C3 shunt, as exemplified by zymosan (Z) and Escherichia coli (E. coli), requires ionized magnesium but not ionized calcium and proceeds in the presence of 10 mM ethyleneglycoltetraacetic acid (EGTA). C-fixation via the C142 pathway requires calcium and is inhibited by EGTA. Both pathways of C-activation are inhibited by ethylenediaminetetraacetic acid (EDTA). EGTA serum may be a useful and simple reagent to distinguish between C142 and C3 shunt-mediated complement activation.

immunology
Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies

Abdelwahab Hassan Ahmed Balola,Beate Mayer,Thilo Bartolmäs,Abdulgabar Salama

DOI: https://doi.org/10.33594/000000150

Abstract:Background/aims: Eryptosis, the suicidal death of red blood cells (RBCs), is characterized by phosphatidylserine (PS) exposure at the cell surface. It can be catalysed by a variety of abnormal conditions and diseases. Until now, the many questions surrounding the physiology and pathophysiology of eryptosis have not been sufficiently answered. Recently, we demonstrated IgM and IgA autoantibodies (aab) to induce PS exposure on circulating RBCs of patients with autoimmune haemolytic anaemia (AIHA). However, it remained unclear how these aab lead to eryptosis. Methods: Serum and plasma samples from patients with clinically relevant AIHA of cold type were used to induce eryptosis in O RBCs. Serum containing fresh complement from healthy donors, antibodies to complement component, and complement factor depleted sera were added to examine the influence of the complement on PS-exposure. RBC bound annexin V PE were analysed by flow cytometry. Results: Eryptosis related to IgM aab was found to be dependent on complement activation and could be effectively inhibited by EDTA, serum heat inactivation and anti-C5. PS exposure increased with sequential activation of the sublytic terminal complement components C5b6, C5b-7 and was most significant at the C5b-8 stage. A decrease was observed following the formation of the lytic membrane attack complex C5b-9, either because of lysis of eryptotic RBCs or because of inhibition of eryptosis by C9. Conclusion: Our findings reflect new aspects on RBC destruction in AIHA as well the impact of the terminal complement complexes on the RBC membrane. The striking differences to nucleated cell apoptosis may even have physiological meaning of RBC acting as a buffer of the complement system.
The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides with Glomerular IgA Deposition

Yanhong Ma,Liangliang Chen,Ying Xu,Quan Han,Binfeng Yu,Jie Zhao,Zhou Hua,Yi Yang,Jianghua Chen,Fei Han

DOI: https://doi.org/10.1097/pai.0000000000000819

IF: 1.992

2019-01-01

Applied Immunohistochemistry & Molecular Morphology

Abstract:The renal injury caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by few or no immune deposits in glomerulus. A growing number of AAV patients with glomerular immunoglobulin (Ig)A deposits have been reported. We retrospectively investigated all AAV patients with glomerular IgA deposits diagnosed in our center. Serum galactose-deficient IgA1 (Gd-IgA1) level and glomerular Gd-IgA1 and IgA staining were measured. Moreover, we detected complement pathway components in their sera. A total of 168 AAV patients were enrolled, including 26 patients with glomerular IgA deposition and 142 patients with pauci-immune-complex deposition. The AAV patients with IgA deposition had a tendency of lower systemic disease activity, presenting with lower erythrocyte sedimentation rate, lower myeloperoxidase-ANCA, and tendency of lower C reactive protein and Birmingham Vasculitis Activity Score. For renal injury, there were no significant differences in clinical data, pathologic parameters, or renal outcome between groups. The serum level of Gd-IgA1 and intensity of glomerular Gd-IgA1 staining in IgA deposition AAV patients were similar to IgA nephropathy patients. All patients in the IgA nephropathy group and AAV groups with or without IgA deposition had the activation of the alternative complement pathway, whereas AAV patients with IgA deposition also had the activation of the classic complement pathway. Correlation analysis showed serum C1q level correlated directly with serum globulin and IgA levels. In conclusion, AAV patients with IgA deposition had the basis of IgA nephropathy and may present lower systemic disease activity. But it differs from pauci-immune AAV or IgA nephropathy by the possible activation of the classic complement pathway.
Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics

Maria Magdalena John,Monika Hunjadi,Vanessa Hawlin,Jean-Baptiste Reiser,Renate Kunert

DOI: https://doi.org/10.3390/life14050638

2024-05-18

Life

Abstract:The interaction between IgM and C1q represents the first step of the classical pathway of the complement system in higher vertebrates. To identify the significance of particular IgM/C1q interactions, recombinant IgMs were used in both hexameric and pentameric configurations and with two different specificities, along with C1q derived from human serum (sC1q) and two recombinant single-chain variants of the trimeric globular region of C1q. Interaction and complement activation assays were performed using the ELISA format, and bio-layer interferometry measurements to study kinetic behavior. The differences between hexameric and pentameric IgM conformations were only slightly visible in the interaction assay, but significant in the complement activation assay. Hexameric IgM requires a lower concentration of sC1q to activate the complement compared to pentameric IgM, leading to an increased release of C4 compared to pentameric IgM. The recombinant C1q mimetics competed with sC1q in interaction assays and were able to inhibit complement activation. The bio-layer interferometry measurements revealed KD values in the nanomolar range for the IgM/C1q interaction, while the C1q mimetics exhibited rapid on and off binding rates with the IgMs. Our results make C1q mimetics valuable tools for developing recombinant C1q, specifically its variants, for further scientific studies and clinical applications.

biology
The Alternative Pathway of Complement Activation May Be Involved in the Renal Damage of Human Anti-Glomerular Basement Membrane Disease

Rui Ma,Zhao Cui,Shui-Yi Hu,Xiao-Yu Jia,Rui Yang,Xin Zheng,Jie Ao,Gang Liu,Yun-Hua Liao,Ming-Hui Zhao

DOI: https://doi.org/10.1371/journal.pone.0091250

IF: 3.7

2014-01-01

PLoS ONE

Abstract:Linear deposition of IgG and complement 3 (C3) along glomerular basement membrane (GBM) is generally revealed in the kidneys of human anti-GBM disease. Our recent studies demonstrated the pathogenic role of complement activation in renal damage of this disease. However, the pathways of complement activation were still paradoxical. In this study, renal biopsy tissues from 10 patients with anti-GBM disease were used to investigate the pathways of complement activation by detecting the deposition of various complement components, including C1q, factor B, factor P (properdin), mannose-binding lectin (MBL), C3d, C4d and C5b-9, using immunohistochemistry and immunofluorescence. We found that C1q, factor B, properdin, C3d, C4d and C5b-9 were detected in all the glomeruli of our patients, along GBM with a linear and/or granular staining pattern. Furthermore, C1q, factor B and properdin co-localized well with C5b-9. The properdin also co-localized well with C3d. However, the deposition of MBL was diffusive in mesangium, GBM, Bowman's capsule and within crescents and was not co-localized with C5b-9 but partially co-localized with C4d. The intensity of factor B deposition (3.3 vs. 1.2, P<0.001) and C5b-9 deposition (3.2 vs. 1.6, P<0.001) was significantly stronger in the glomeruli with crescent formation, compared with the glomeruli without crescents. The complement system is overall activated via both the alternative pathway and classical pathway in the kidneys of human anti-GBM disease. The alternative pathway might play an important role in complement activation induced renal damage.
Danish patients with alcoholic cirrhosis have a low risk of hepatocellular carcinoma thus raising questions about the utility of screening

Jamilé Wakim-Fleming,R. Lopez

DOI: https://doi.org/10.1136/eb-2012-100959

2012-10-20

Evidence-Based Medicine

Abstract:Commentary on: Jepsen P, Ott P, Andersen PK, et al. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 2012; 156: 841– 7.[OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Alcohol consumption is increasing worldwide.1 As this trend continues, so is the associated morbidity and mortality.2 ,3 Alcohol causes cirrhosis and hepatocellular carcinoma (HCC). Amount and duration of consumption are the two most important risk factors.3 ,4 The incidence rates for HCC have tripled during the past decades5 and alcoholic cirrhosis is a major contributing factor. Abstinence improves survival.4 Most HCC in alcoholics occur in cirrhosis. Surveillance is recommended when HCC risk exceeds 1.5% per year and the cost is <$50 000/year of life gained. Guidelines state that alcoholic cirrhosis is probably sufficient to warrant … [1]: {openurl}?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DJepsen%26rft.auinit1%253DP.%26rft.volume%253D156%26rft.issue%253D12%26rft.spage%253D841%26rft.epage%253D847%26rft.atitle%253DRisk%2Bfor%2Bhepatocellular%2Bcarcinoma%2Bin%2Bpatients%2Bwith%2Balcoholic%2Bcirrhosis%253A%2Ba%2BDanish%2Bnationwide%2Bcohort%2Bstudy.%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-156-12-201206190-00004%26rft_id%253Dinfo%253Apmid%252F22711076%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.7326/0003-4819-156-12-201206190-00004&link_type=DOI [3]: /lookup/external-ref?access_num=22711076&link_type=MED&atom=%2Febmed%2F18%2F4%2F155.atom [4]: /lookup/external-ref?access_num=000307783200013&link_type=ISI
Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides

Wiesław Kaca,Michał Arabski,Rafał Fudała,Eva Holmström,Anders Sjöholm,Andrej Weintraub,Bozena Futoma-Kołoch,Gabriela Bugla-Płoskońska,Włodzimierz Doroszkiewicz

DOI: https://doi.org/10.1007/s00005-009-0043-8

Abstract:Introduction: Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and methods: The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results: The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion: Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.
Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation

Marit Saethre,Tor Lea,Merethe S Borgen,Arnt E Fiane,Terje E Michaelsen,Erik Thorsby,Guttorm Haraldsen,Tom E Mollnes

DOI: https://doi.org/10.1111/j.1399-3089.2006.00289.x

Xenotransplantation

Abstract:Background: Complement-activating naturally occurring anti-porcine endothelial cell antibodies (Abs) are responsible for hyperacute rejection in porcine-to-primate transplantation, whereas the role of complement in acute vascular rejection, characterized by type II endothelial cell activation, is less well understood. We previously demonstrated a correlation between porcine type II endothelial cell activation, as detected by E-selectin expression, and human immunoglobulin (Ig)G3 anti-Gal alpha1-3Gal (Gal) Abs, which was not seen for IgG1, IgG2 or IgG4. The present study was undertaken to investigate whether there is a causal relationship between human anti-porcine IgG3 Abs and porcine endothelial cell activation. Methods: IgG3 was isolated employing a Protein A column to 98.3% purity. Porcine endothelial cells were incubated with isolated human IgG3 or the combination of IgG1, IgG2 and IgG4. E-selectin expression and complement activation were investigated by flow cytometry and Western blotting, respectively. Results: Purified IgG3, in contrast to the other IgG subclasses, induced a substantial increase in E-selectin expression. This activation was accompanied by complement activation as detected by C3 cleavage, and was abolished by heat inactivation or by adding the complement inhibitor FUT-175. Depletion of anti-Gal Abs reduced E-selectin expression by 60%, consistent with the presence of complement-activating anti-porcine non-Gal Abs of the IgG3 subclass. Conclusions: Collectively, these data strengthen the hypothesis that human anti-porcine endothelial cell Abs of the IgG3 subclass are essential for endothelial cell activation in porcine-to-human species grafts and demonstrate such activation to be partly independent of Gal epitopes.
Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis

Yu-Fang Huang,Kerstin Sandholm,Barbro Persson,Bo Nilsson,Anna Rostedt Punga

DOI: https://doi.org/10.1002/mus.28227

Abstract:Introduction/aims: There are no blood biomarkers to monitor treatment effects in myasthenia gravis (MG) or studies visualizing the acetylcholine receptor (AChR) antibody-induced membrane attack complex (MAC) at the human muscle membrane. This study aimed to compare levels of complement activation products and native complement components in MG patients and healthy controls (HCs) and to model the AChR antibody-mediated attacks in human muscle cells. Methods: We assessed the complement components and activation product levels with enzyme-linked immunosorbent assay and magnetic bead-based sandwich assays in plasma and sera of 23 MG patients and matched HCs. Receiver operator characteristic (ROC) curve analysis evaluated the diagnostic accuracy. Complement levels were correlated with the myasthenia gravis composite (MGC) scores. AChR+ MG modeling in human muscle cells used sera from nine MG patients and three HCs. Results: MG patients had significantly higher plasma levels of C3a (p < .0001), C5 (p = .0003), and soluble C5b-9 (sC5b-9; p < .0001) than HCs. The ROC curve analysis showed a clear separation between MG patients and HCs for plasma C3a (AUC = 0.9720; p < .0001) and sC5b-9 (AUC = 0.8917, p < .0001). MG patients had higher levels of plasma complement Factor I (FI; p = .0002) and lower properdin levels (p < .0001). The MGC had moderate correlations with plasma Factor B (FB), FI, and Factor H. AChR+ MG patient sera triggered the deposition of MAC and reduced AChRs. Discussion: We suggest validating plasma C3a and sC5b-9 as blood biomarkers for complement activation in MG. Further, the in vitro study allowed visualization of MAC deposition after applying AChR+ MG sera on human muscle cells.
Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events.

M. Robinson,D. Andrew,H. Rosen,Derek Brown,S. Ortlepp,P. Stephens,E. Butcher

DOI: https://doi.org/10.4049/jimmunol.148.4.1080

1992-02-15

Abstract:The Leukocytic cell-adhesion molecule (beta 2 integrin) family of adhesion molecules play a key role in the intercellular adhesive interactions necessary for normal immune cell function. In this study, we report an antibody that recognizes an epitope on the Leukocytic cell-adhesion molecule common beta-chain (CD18) and promotes both lymphocyte function-associated Ag-1- and CR3-dependent adhesion events. The antibody recognizes a temperature-sensitive epitope that is not dependent on the presence of divalent cations. It is proposed that antibody binding promotes a conformational change in both lymphocyte function-associated Ag-1 and CR3, which may mimic a natural activation mechanism, resulting in increased cellular adhesion.

My Path from Hiroshima to Houston.

Towards better uncertainty handling based on zSlices and general type-2 fuzzy logic systems

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Postoperative surgical site infections in cardiac surgery —an overview of preventive measures

The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

Teaching Test-Taking Strategies to Improve the Academic Achievement of Students with Mild Mental Disabilities.

The role of gamma globulin, complement component 1q, factor B, properdin, body temperature, C-reactive protein and serum amyloid alpha to the activity and the function of the human complement system and its pathways

Factors affecting IgG4-mediated complement activation

Mode of complement activation by acidic heteroglycans from the leaves of Artemisia princeps PAMP

Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

The Fc fragment of soluble IgMs binds C1q to activate the classical complement pathway, while inhibiting complement-dependent cytotoxicity

C3 Shunt Activation in Human Serum Chelated with EGTA

Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies

The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides with Glomerular IgA Deposition

Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics

The Alternative Pathway of Complement Activation May Be Involved in the Renal Damage of Human Anti-Glomerular Basement Membrane Disease

Danish patients with alcoholic cirrhosis have a low risk of hepatocellular carcinoma thus raising questions about the utility of screening

Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides

Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation

Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis

Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events.